|
George Stark is a distinguished expert in the fields of biochemistry, signal transduction and cancer biology who has pioneered many key technologies in the fields of molecular biology and genetics. The author of over 220 articles, Dr. Stark contributed to the development of the Western and Northern techniques in protein and nucleic acid chemistry. His newer work has focused on the application of systematic genetics to interferon signaling pathways leading to the discovery of the JAK-STAT family of proteins, which mediate responses to many different extracellular factors. Dr. Stark earned a Ph.D. degree in Chemistry from Columbia University in 1959. After a postdoctoral fellowship at the Rockefeller University, he joined the Department of Biochemistry at Stanford University in 1963, becoming Professor in 1971. In 1983, he moved to the Imperial Cancer Research Fund in London. In 1992, he became the Chair of the Lerner Research Institute of The Cleveland Clinic. Dr. Stark was elected to the National Academy of Sciences in 1986 and to the fellowship of the Royal Society in 1990. He was recently elected into the Medical Institute of the National Academy of Sciences. Dr. Stark serves on Scientific Advisory Boards of many biotech companies, including Amersham Biosciences, Sunesis, Lorus Therapeutics and others. | 